Pretransplant conditioning with fludarabine and IV busulfan, reduced toxicity and increased safety without compromising antitumor efficacy and overall treatment effect?
Crossref DOI link: https://doi.org/10.1038/bmt.2016.110
Published Online: 2016-04-25
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Andersson, B S
Valdez, B C
Text and Data Mining valid from 2016-04-25
Version of Record valid from 2016-04-25
Article History
Received: 17 March 2016
Accepted: 19 March 2016
First Online: 25 April 2016
Competing interests
: The authors declare no conflict of interest.